Pre-Lunch Industry Symposium:
Push the paradigm: Advances in treating HER2-expressing metastatic breast cancer
Sponsored by Daiichi Sankyo UK and AstraZeneca UK. This is a promotional symposium organised and funded by Daiichi Sankyo UK and AstraZeneca UK, at which Daiichi Sankyo and AstraZeneca products will be discussed within their UK Marketing Authorisations.
UK/ADC/07/24/0032 | July 2024
Thursday, September 12, 2024
12:30-13:30
HALL A
| 12:30-12:50 |
How I manage HER2-positive metastatic breast cancer |
| 12:50-13:10 |
Recent advances in HER2-expressing metastatic breast cancer treatments |
| 13:10-13:30 |
Panel discussion and questions from the audience |